Assignee
MINK THERAPEUTICS INC
US·4 granted patents·3 pending applications·1 citations·filing 2016–2025
Top patents by PatentIndex Score
7 records- 0176US11718658B2T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereofMINK THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·1 cites·21 claims
- 0270US12391741B2T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 0364US2024102044A1T cell receptors that bind to ny-eso-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US11613764B2T cell receptors that bind to NY-ESO-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2019·Granted Mar 28, 2023·0 cites·8 claims
- 0557US2025339529A1B-cell maturation antigen (bcma) chimeric antigen receptor invariant natural killer t cells and uses thereofMINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0647US2025339468A1Invariant natural killer t cells for treating acute respiratory distress syndrome (ards)MINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0744US11898165B2Engineered host cells and methods of use thereofMINK THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2024·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →